Submit Press Release GroupWeb News Network Africa Alabama Alaska Arizona Arkansas Asia California China Colorada Connecticut Washington DC Delaware Florida France Georgia Germany Ghana Hawaii Idaho Illinois India Indiana Iowa Italy Japan Kansas Kentucky Korea Lousiana Main MaryLand Massachusetts Michigan Minnesota Mississippi Misouri Motana Nebraska Nevad New Hampshire New Jersey New Mexico New York Nigeria North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island Rhode Island Russia South Africa South Carolina South Dakota Spain Tennessee Texas UK Utah Vermont Virginia Washington Weather West Virginia Wisconsin

Home | Search Global IT News: IT News & Press Release Distribution: Biosimilars Market in India 2017   (IT-NEWSWIRE.COM, January 24, 2018 ) Publisher latest market research report titled Biosimilars Market in India 2017, describes the current and forecasted dynamics of the biosimilars market in India. The increasing incidence of diseases such as CVD and CHD, cancer and diabetes has led to an increase in the demand for these products and has resulted in the growth of this industry in India. Biosimilars are typically marketed at prices that are 25% to 40% below the prices of original branded products. This has been the primary appeal to customers. Moreover, the rise in the number and quality of tertiary care centers is resulting in the greater usage of these products. Rising drug costs, limited healthcare budgets across the world and patent expiries of biotechnology drugs have created a huge opportunity for biosimilar manufacturers. There aren't too many players in the market and the industry is dominated by a small number of sellers leaving a room for the new entrants in the market. For more information about this report at http://www.reportsweb.com/biosimilars-market-in-india-2017 However, required capital investment and operating costs for manufacturing is much higher for biosimilars than for generic drugs. The process to develop a generic version of biosimilar is also complex than developing a generic copy of a chemical-based compound. Extensive funding is required due to emerging rigorous regulatory requirements which act as a challenge for the players in the industry. Lack of widespread awareness towards the biosimilar products is also acting as a drawback for the industry as people tend to avoid using biosimilar products. The stringent regulatory framework of the healthcare industry which requires biosimilars to undergo several regulatory measures is cumbersome for companies looking to constantly innovate and launch new products in the market. Although there are challenges in the industry, the market for biosimilars is expected to grow with more players entering the market and development of new biosimilar products for the treatment of chronic diseases. Companies Mentioned Public Companies 1. Biocon Limited 2. Dr. Reddy's Laboratories Limited 3. Lupin Limited 4. Cipla Limited 5. Zenotech Laboratories Limited 6. Wockhardt Limited Private Companies 1. Intas Pharmaceuticals Limited 2. Bharat Biotech Limited 3. Reliance Life Sciences Private Limited 4. Shantha Biotechnics Private Limited Request a sample copy at http://www.reportsweb.com/inquiry&RW00011190695/sample Table of Content Slide 1: Executive Summary Socioeconomic Indicators Slide 2: Total Population (2010-2011-2019-2020), Population Density (2010-2011-2019-2020) Slide 3: Sex Ratio (2005, 2010, 2015, 2020), Population by Age Group (2005, 2010, 2015, 2020), Urbanization Trend (2010-2011-2019-2020) Slide 4: Total Fertility Rate (2005-2010, 2010-2015, 2015-2020), Infant Mortality Rate (2005-2010, 2010-2015, 2015-2020), Total Number of Births (2005-2010, 2010-2015, 2015-2020), Total Number of Death (2005-2010, 2010-2015, 2015-2020) Slide 5: Total Literacy Rate (2001, 2011), Rural Literacy (2001, 2011), Urban Literacy (2001, 2011) Slide 6: GDP at Market Prices (2010-2014), FDI (2010-2014), Inflation Rate (2010-2014), Unemployment Rate (2010-2014) Slide 7: Access to Safe Drinking Water (2001, 2011), Exchange Rate (2010-2015) Market Overview Slide 8: Market Definition and Structure Slide 9: Biosimilars Market in India-Overview, Size and Growth (Value-Wise, 2011-2020e) Slide 10: Regulatory Bodies and Guidelines Market Opportunity Slide 11: Future Growth Opportunities for the Market Market Influencers Slide 12: Market Drivers Slide 13: Market Challenges Competitive Landscape Slide 14: List of Major Players Slide 15-36: Profiles of Major Players Recent Developments Slide 37-42: Key Recent Developments Appendix Slide 43: Research Methodology Inquire for Report at http://www.reportsweb.com/inquiry&RW00011190695/buying ReportsWeb.com Rajat Sahni +1-646-491-9876 sales@reportsweb.com Source: EmailWire.Com Source: EmailWire.com

Information Technology Resources Application Software Bioinformatics Computers Computer Games Enterprise Software Graphics/Printing/CAD Hardware/Peripheral industrial Computers Information Internet Multimedia Networking Public Sector Robotics Semiconductor Software Telecommunications Webmaster Information Technology (IT) Advertisement Information Technology Sponsors Information Technology Publications We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Information Technology resource center today to browse our selection of 600+ complimentary Information Technology magazines, white papers, webinars, podcasts, and more. Get popular titles including: The Integration Journey—a Field Guide to Enterprise Integration for SOA Government Technology\'s Public CIO Protecting Content During Business Disruption: Are You Covered? No credit cards, coupons, or promo codes required. Try it today!